Sarah P Young Selected Research

glucose tetrasaccharide

3/2021	Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III.
1/2015	Baseline Urinary Glucose Tetrasaccharide Concentrations in Patients with Infantile- and Late-Onset Pompe Disease Identified by Newborn Screening.
2/2012	Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
7/2009	Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker.
8/2005	Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease.
5/2003	Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah P Young Research Topics

Disease

25	Glycogen Storage Disease Type II (Pompe's Disease) 06/2020 - 05/2003
6	Mucopolysaccharidoses 09/2020 - 01/2011
4	Fabry Disease (Fabry's Disease) 12/2020 - 07/2009
3	Glycogen Storage Disease Type III (Cori's Disease) 12/2021 - 12/2019
3	Disease Progression 12/2021 - 12/2011
3	Hepatorenal form of glycogen storage disease 01/2020 - 01/2019
2	Liver Diseases (Liver Disease) 12/2021 - 02/2016
2	Muscle Weakness 12/2021 - 11/2005
2	Fibrosis (Cirrhosis) 12/2021 - 02/2016
2	Glycogen Storage Disease (Glycogenosis) 03/2021 - 02/2016
2	Hypertriglyceridemia 01/2020 - 01/2019
2	Lactic Acidosis 01/2020 - 09/2015
2	Muscular Diseases (Myopathy) 01/2020 - 09/2015
2	Hypoglycemia (Reactive Hypoglycemia) 01/2020 - 09/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2019 - 02/2016
2	Down Syndrome (Down's Syndrome) 12/2012 - 06/2010
2	Short chain Acyl CoA dehydrogenase deficiency 11/2003 - 08/2003
1	Nonketotic Hyperglycinemia 01/2022
1	Corneal Opacity 01/2022
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2022
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2022
1	Hepatomegaly 12/2021
1	Glycogen Storage Disease IIIB 12/2021
1	Portal Hypertension 12/2021
1	Gaucher Disease (Gaucher's Disease) 12/2020
1	Mucopolysaccharidosis I (Hurler Syndrome) 09/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2020
1	Atrophy 01/2020
1	Bronchopulmonary Dysplasia 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Liver Cell Adenoma (Hepatocellular Adenoma) 01/2020
1	Fatty Liver 01/2020
1	Tremor (Tremors) 01/2020
1	Spasm (Spasms) 01/2020
1	Parasitemia 12/2019
1	Inflammation (Inflammations) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Glycogen Storage Disease Type I 01/2019
1	Homocystinuria 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018

Drug/Important Bio-Agent (IBA)

17	AcidsIBA 06/2020 - 08/2003
16	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2003
15	GlycogenIBA 12/2021 - 05/2003
13	EnzymesIBA 01/2022 - 12/2006
10	alpha-Glucosidases (Acid Maltase)IBA 01/2015 - 01/2005
9	human GAA protein (Myozyme)FDA Link 01/2020 - 08/2005
6	GlycosaminoglycansIBA 01/2022 - 01/2011
6	glucose tetrasaccharideIBA 03/2021 - 05/2003
6	GlucosidasesIBA 06/2020 - 01/2012
3	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 01/2020 - 01/2019
2	Heparitin Sulfate (Heparan Sulfate)IBA 09/2020 - 02/2015
2	Dermatan SulfateIBA 09/2020 - 02/2015
2	Albuterol (Salbutamol)FDA LinkGeneric 01/2020 - 05/2014
2	GalactosidasesIBA 01/2020 - 12/2010
2	globotriaosyl lysosphingolipidIBA 01/2020 - 12/2010
2	globotriaosylceramide (globotriosylceramide)IBA 01/2020 - 12/2010
2	BezafibrateIBA 06/2019 - 01/2019
2	AntioxidantsIBA 01/2019 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 03/2009
2	Carnitine (L-Carnitine)FDA LinkGeneric 09/2015 - 08/2003
2	Biological ProductsIBA 04/2012 - 05/2003
2	IsotopesIBA 07/2011 - 05/2003
2	acylcarnitineIBA 11/2003 - 08/2003
2	Butyryl-CoA Dehydrogenase (Short-Chain Acyl-CoA Dehydrogenase)IBA 11/2003 - 08/2003
1	ChondroitinIBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	odiparcilIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2021
1	DextrinsIBA 03/2021
1	Starch (Cornstarch)IBA 03/2021
1	sphingosyl beta-glucosideIBA 12/2020
1	Fenofibrate (CiL)FDA LinkGeneric 01/2020
1	Gastrin-Releasing PeptideIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	LipidsIBA 01/2020
1	Liver GlycogenIBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Transaminases (Aminotransferases)IBA 12/2019
1	dimethylmethylene blueIBA 12/2019
1	CystathionineIBA 01/2019
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2019
1	Glucose-6-PhosphateIBA 01/2019
1	Taurine FDA Link 01/2019
1	HomocysteineIBA 01/2019
1	Acetylcarnitine (Alcar)IBA 01/2018

Therapy/Procedure

16	Enzyme Replacement Therapy 09/2020 - 05/2003
12	Therapeutics 03/2021 - 07/2009
2	Mechanical Ventilators (Ventilator) 12/2011 - 11/2007
2	Drug Therapy (Chemotherapy) 01/2011 - 06/2010
1	Diet Therapy (Therapy, Diet) 12/2021
1	Aftercare (After-Treatment) 09/2020
1	Contraindications 01/2020
1	Precision Medicine 01/2018